Previous 10 | Next 10 |
Immediate reaction to yesterday's announcement of a big merger of healthcare contract research organizations has Baird raising targets on each company, saying it looks like two good firms with an interesting case for coming together. Initial feedback on the deal for ICON plc's (ICLR) $12B acq...
Image source: The Motley Fool. Icon PLC (NASDAQ: ICLR) Q4 2020 Earnings Call Feb 25, 2021 , 9:00 a.m. ET Operator Continue reading For further details see: Icon PLC (ICLR) Q4 2020 Earnings Call Transcript
Looking For The Best Health Care Stocks To Watch Right Now? 4 Names To Know You can’t deny that health care is a vital industry in the world we live in today. Similarly, health care stocks have and will likely continue to fill the same role in the stock market. With all e...
Shares of PRA Health Sciences (NASDAQ: PRAH) , a contract research organization (CRO), are jumping on Wednesday and were up by 18.2% as of 1:27 p.m. EST. There are two reasons investors are bidding up PRA Health Sciences' stock today. First, the company reported better-than-expected...
William Blair analyst John Kreger likes what he sees with ICON plc's (ICLR) $12B acquisition of PRA Health Sciences (PRAH) announced earlier today."We know that ICON has been striving for greater scale in the business and PRA Health should be a very complementary fit in terms of customer...
LabCorp (LH) sum-of-the-parts value is $313 share, 27% higher than its current price, as activist Jana may unlock the value in the company's Covance business, according to Credit Suisse.LabCorp's Covance CRO business is "woefully underappreciate," Credit Suisse analyst Erin Wilson Wright says...
PRA Health Sciences (PRAH) has surged ~19.0% in the premarket after agreeing to be acquired by ICON plc (ICLR) in a cash and stock transaction valued at ~$12B.Per the terms of the agreement, PRA investors will receive $80 in cash and 0.4125 shares of ICON stock for each PR...
Icon (ICLR): Q4 GAAP EPS of $1.90 beats by $0.07.Revenue of $760.22M (+4.8% Y/Y) beats by $10.06M.Press Release For further details see: Icon EPS beats by $0.07, beats on revenue
Highlights Record net business wins in the quarter of $1,080 million; a book to bill of 1.42. Full year net business wins of $3.8 billion; a net book to bill of 1.38. Record closing backlog of $9.7 billion, an increase of 13.4% year on year. Quarter 4 reported ...
The consolidation brings together two organizations with a history of robust growth and performance ready to build on this strength using the outstanding talent of both companies to deliver enhanced value to patients, customers, employees and shareholders. All cust...
News, Short Squeeze, Breakout and More Instantly...
Highlights Net business wins in the quarter of $2,579 million, an increase of 6.6% on quarter two 2023. Reflects a net book to bill in the quarter of 1.22, and a trailing twelve month net book to bill of 1.24. Closing backlog of $23.8 billion, an increase of 2.0% on quarter one 20...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that all resolutions at the Annual General Meeting of the company (AGM) held on July 23, 2024 were duly passed by shareholders. ICON also confirmed that following the conclus...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading business and industry awards recognising the company’s leadership position in the clinical research industry, in addi...